Despite all activity, however, the only approved treatment modalities for AD are acetylcholinesterase (AChE) inhibitors and memantine, which merely serve as symptomatic cognitive-enhancing drugs and cannot alter the course of the disease [2]. This evidence concerns the gene ACHE and Alzheimer disease.